GROUNDBREAKING RESEARCH ICR scientist wins Young Investigator Award for BRCA2 research
More research stories:
ICR scientist Dr. Rachel Brough, from the Breakthrough Breast Cancer Research Centre, was co-winner of the 2008 British Oncology Association Young Investigator Award for her work on BRCA2 function. This was awarded at the National Cancer Research Institute conference last October. Her research used Drosophila (fruit flies) to study the BRCA2 protein, which is involved in cancer susceptibility in humans. The study of a less complex organism has provided valuable insight into how BRCA2 contributes to cancer in humans.
Related Stories
- Childhood leukemia stem cells develop in pregnancy This study of twins in which one has leukemia has identified the critical stem cells that initiate the disease and maintain it in a covert state for several years.
- Light shed on the mechanism behind cancer metastasis "The spread of cancer cells from one part of the body to another, called metastasis, is one of the biggest causes of death from cancer. By explaining a key part of that process, our research brings new hope for future therapies to fight cancer." Chris Marshall, ICR Professor of Cell Biology and Oncogene Team Leader
- Breakthrough in breast cancer drug resistance Scientists’ new understanding of drug resistance has important implications for women with breast cancer.
- ICR scientist wins Young Investigator Award for BRCA2 research Dr. Rachel Brough was co-winner of the 2008 British Oncology Association Young Investigator Award for her work on BRCA2 function.
- Shorter radiotherapy courses for breast cancer "These trials represent a successful ten-year collaboration between cancer specialists and several thousand women motivated to help others by volunteering for research." John Yarnold, ICR Professor of Clinical Oncology
- Colorectal, leukemia and lung cancer genes found This is the first time that common genetic variations have been associated with the risk of developing colorectal cancer.
- Seven new prostate cancer genetic variants found This international study of 10,000 men is the largest study into the genetic causes of prostate cancer to date. Its results will help scientists to calculate the risk of developing prostate cancer and may lead to the development of better targeted screening and treatment.
